Abstract
There is an unmet need to develop alternative therapeutic strategies to not only restrain seizures but also to alleviate the underlying pathologies and sequelae. Berberine (BBR), an isoquinoline alkaloid, has shown promising effect in the kindling model of epileptogenesis, but due to the poor oral bioavailability its clinical application is limited. So, the present study was designed to study the neuroprotective effect of BBR nanoparticles (enhanced bioavailability as compared to BBR) against seizures in pentylenetetrazole (PTZ) induced kindling model of epileptogenesis. Kindling model was established in male Wistar rats by intraperitoneal (i.p.) administration of PTZ (30 mg/kg) on every alternate day till the animal became fully kindled or till 6 weeks. Three doses of BBR (50, 100, and 200 mg/kg) and nano-BBR (25, 50, 100 mg/kg) were studied for seizure score, percentage of animal kindled, histopathological score, oxidative stress, inflammation, and apoptosis in PTZ treated rats by conducting cytokines, gene expression and protein expression analysis. BBR nanoparticles showed significant effect on the seizure score and percentage of animal kindled, histopathological score, neurobehavioral parameters (Forced swim test, Rotarod), oxidative (MDA, SOD, GSH, GPx) and inflammatory (IL-1beta, TNF-alpha) parameters, apoptotic parameters (Bax and iNOS), and gene (Nrf2, NQO1, HO1) and protein expression (Nrf2) as compared to both PTZ and BBR. BBR nanoparticles showed neuroprotective effect in PTZ induced kindling model of epileptogenesis and proves to be a promising antiepileptogenic therapy for the patients who are at high risk of developing seizures.
Graphical Abstract
Similar content being viewed by others
Data Availability
Data will be available on request.
References
Beghi E, Giussani G, Nichols E, Abd-Allah F, Abdela J, Abdelalim A et al (2019) Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:357–375
Brooks-Kayal AR, Bath KG, Berg AT, Galanopoulou AS, Holmes GL, Jensen FE et al (2013) Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia 54:44–60
Quintas R, Alvarez AS, Koutsogeorgou E, Cerniauskaite M, Meucci P, Sattin D et al (2012) The relationship between health-related quality-of-life and disability in patients with controlled epilepsy: a cross-sectional observational study. Am J Phys Med 91:S31–S38
Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69:16–24
Shimada T, Takemiya T, Sugiura H, Yamagata K (2014) Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm. https://doi.org/10.1155/2014/901902
Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L (2014) The role of oxidative stress during inflammatory processes. Biol Chem 395:203–230
Martinc B, Grabnar I, Vovk T (2012) The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr Neuropharmacol 10:328–343
Goldberg EM, Coulter DA (2013) Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 14:337–349
Macleod S, Appleton RE (2007) The new antiepileptic drugs. Arch Dis Childhood-Edu Pract 92:182–188
Schachter SC (2002) Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic. Epilepsy Res 50:67–70
Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42:515–524
Panayiotopoulos CP (2007) Old versus new antiepileptic drugs: the SANAD study. Lancet 370:313–314
Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V (2018) The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis. Epilepsia 59:2179–2193
Shou JW, Shaw P-C (2022) Therapeutic efficacies of berberine against neurological disorders: an update of pharmacological effects and mechanisms. Cells 11:796
Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phyther Res An Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv 24:317–324
Kumar A, Chopra K, Mukherjee M, Pottabathini R, Dhull DK (2015) Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol 761:288–297
Guna V, Saha L, Bhatia A, Banerjee D, Chakrabarti A (2018) Anti-oxidant and anti-apoptotic effects of berberine in pentylenetetrazole-induced kindling model in rat. J epilepsy Res Korean Epilepsy Society 8:66–73
Mojarad TB, Roghani M (2014) The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats. Basic Clin Neurosci Iranian Neurosci Society 5:124–130
Sadeghnia HR, Taji AR, Forouzanfar F, Hosseinzadeh H (2017) Berberine attenuates convulsing behavior and extracellular glutamate and aspartate changes in 4-aminopyridine treated rats. Iran J Basic Med Sci 20:588
Hua W, Ding L, Chen Y, Gong B, He J, Xu G (2007) Determination of berberine in human plasma by liquid chromatography–electrospray ionization–mass spectrometry. J Pharm Biomed Anal 44:931–937
Liu Y, Hao H, Xie H, Lv HUA, Liu C, Wang G (2009) Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J Pharm Sci 98:4391–4401
Liu Y-T, Hao H-P, Xie H-G, Lai L, Wang Q, Liu C-X et al (2010) Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos ASPET 38:1779–1784
Maeng H-J, Yoo H-J, Kim I-W, Song I-S, Chung S-J, Shim C-K (2002) P-glycoprotein–mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci 91:2614–2621
Kumar G, Malhotra S, Shafiq N, Pandhi P, Khuller GK, Sharma S (2011) In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis. J Microencapsul 28(8):717–728
Shigwan H, Saklani A, Hamrapurkar PD, Mane T, Bhatt P (2013) HPLC method development and validation for quantification of berberine from Berberis aristata and Berberis tinctoria. Int J Appl Sci Eng 11(2):203–211
Gupta YK, Veerendra Kumar MH, Srivastava AK (2003) Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats. Pharmacol Biochem Behav 74:579–585
Mehla J, Reeta KH, Gupta P, Gupta YK (2010) Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci 87:596–603
Lüttjohann A, Fabene PF, van Luijtelaar G. A revised Racine’s scale for PTZ-induced seizures in rats. Physiol Behav [Internet]. 2009 [cited 2018 Feb 19];98:579–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19772866
Myung RJ, Petko M, Judkins AR, Schears G, Ittenbach RF, Waibel RJ et al (2004) Regional low-flow perfusion improves neurologic outcome compared with deep hypothermic circulatory arrest in neonatal piglets. J Thorac Cardiovasc Surg 127:1051–1057
Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529
Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A et al (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:1331–1340
Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol Elsevier 47:379–391
Classics Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J biol Chem 193:265–275
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem [Internet]. 1979 [cited 2018 Feb 19];95:351–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36810
Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C et al (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med Nature Publishing Group 10:1344–1351
Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med [Internet]. 1967 [cited 2018 Feb 19];70:158–69. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6066618
Lowry H, Nira J, Rosebrough A, Farr L, Randall J (1994) protein measurement with the folin phenol reagent. Anal Biochem 217:220–230
Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol. https://doi.org/10.1155/2010/479364
Thomson SR, Mamulpet V, Adiga S (2017) Sodium valproate induced alopecia: a case series. J Clin Diagn Res 11:1–2
Szaflarski JP, Nazzal Y, Dreer LE (2014) Post-traumatic epilepsy: current and emerging treatment options. Neuropsychiatr Dis Treat 10:1469
Miziak B, Konarzewska A, Ułamek-Kozioł M, Dudra-Jastrzębska M, Pluta R, Czuczwar SJ (2020) Anti-epileptogenic effects of antiepileptic drugs. Int J Mol Sci 21:2340
Frantseva MV, Perez Velazquez JL, Tsoraklidis G, Mendonca AJ, Adamchik Y, Mills LR et al (2000) Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 97:431–435
Naseer MI, Ullah N, Ullah I, Koh PO, Lee HY, Park MS et al (2011) Vitamin C protects against ethanol and PTZ-induced apoptotic neurodegeneration in prenatal rat hippocampal neurons. Synapse 65:562–571
Zhu X, Dong J, Han B, Huang R, Zhang A, Xia Z et al (2017) Neuronal nitric oxide synthase contributes to PTZ kindling epilepsy-induced hippocampal endoplasmic reticulum stress and oxidative damage. Front Cell Neurosci. https://doi.org/10.3389/fncel.2017.00377
Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV, de Vasconcelos A, Wasterlain C et al (1998) Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci Society for Neuroscience 18:3273–3281
Anaeigoudari A, Hosseini M, Karami R, Vafaee F, Mohammadpour T, Ghorbani A et al (2016) The effects of different fractions of Coriandrum sativum on pentylenetetrazole-induced seizures and brain tissues oxidative damage in rats. Avicenna J phytomedicine 6:223–235
Ding K, Wang H, Xu J, Li T, Zhang L, Ding Y et al (2014) Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: The Nrf2-ARE signaling pathway as a potential mechanism. Free Radic Biol Med Elsevier 73:1–11
Shin E-J, Jeong JH, Chung YH, Kim W-K, Ko K-H, Bach J-H et al (2011) Role of oxidative stress in epileptic seizures. Neurochem Int NIH Public Access 59:122–137
Wang W, Wu Y, Zhang G, Fang H, Wang H, Zang H et al (2014) Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure. Brain Res Elsevier 1544:54–61
Zhang JM, Hong Y, Yan W, Chen S, Sun CR (2010) The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol Sin 31:1421–1430
Kaspar JW, Niture SK, Jaiswal AK (2009) Nrf 2:INrf(Keap1) Signaling in oxidative stress. Free Radic Biol Med 47:1304–1309
van Muiswinkel FL, Kuiperij HB (2005) The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord 4:267–281
Ma Q (2013) Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401–426
Benedict AL, Mountney A, Hurtado A, Bryan KE, Schnaar RL, Dinkova-Kostova AT et al (2012) Neuroprotective effects of sulforaphane after contusive spinal cord injury. J Neurotrauma 29:2576–2586
Zhang M, An C, Gao Y, Leak RK, Chen J, Zhang F (2013) Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol NIH Public Access 100:30–47
Das RK, Brar SK, Verma M (2016) Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics. Pharmacol Reports Elsevier 68:404–414
Wang W, Wang W, ping, Zhang G liang, Wu Y fen, Xie T, Kan M chen, et al (2013) Activation of Nrf2-ARE signal pathway in hippocampus of amygdala kindling rats. Neurosci Lett 543:58–63
Niture SK, Jaiswal AK (2012) Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis. J Biol Chem 287:9873–9886
Henshall DC, Chen J, Simon RP (2000) Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J Neurochem 74:1215–1223
Engel T, Henshall DC (2009) Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? Int J Physiol Pathophysiol Pharmacol 1:97–115
Liou AKF, Clark RS, Henshall DC, Yin X-M, Chen J (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog Neurobiol Elsevier 69:103–142
Henshall DC, Simon RP (2005) Epilepsy and Apoptosis Pathways. J Cereb Blood Flow Metab 25:1557–1572
Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F et al (2011) Cytokines and epilepsy. Seizure 20:249–256
Kwon YS, Pineda E, Auvin S, Shin D, Mazarati A, Sankar R (2013) Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J Neuroinflammation 10:1–6
Walker L, Sills GJ (2012) Inflammation and epilepsy: the foundations for a new therapeutic approach in epilepsy? Epilepsy Curr American Epilepsy Society 12:8–12
Vezzani A, Balosso S, Ravizza T (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22:797–803
De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F et al (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12:2623–2633
Minami M, Kuraishi Y, Satoh M (1991) Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain. Biochem Biophys Res Commun 176:593–598
Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A et al (2004) Temporal patterns of the cerebral inflammatory response in the rat lithium–pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 17:385–402
Wood PL (2003) Microglia: Roles of microglia in chronic neurodegenerative diseases. In: PL W (ed) Neuroinflammation Mech Manag. Humana Press, Totowa, pp 3–27
Dingledine R, Varvel NH, Dudek FE (2014) When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv Exp Med Biol. NIH Public Access 813:109–122
Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S et al (2008) Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76:1485–1489
Wilms H, Sievers J, Rickert U, Rostami-yazdi M, Mrowietz U, Lucius R (2010) Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation 7:1–8
Vandermeeren M, Janssens S, Wouters H, Borghmans I, Borgers M, Beyaert R (2001) Dimethylfumarate is an Inhibitor of Cytokine-Induced Nuclear Translocation of NF-κB1, But Not RelA in Normal Human Dermal Fibroblast Cells. J Invest Dermatol Elsevier Masson SAS 116:124–130
Acknowledgements
The authors acknowledge the technical assistance provided by Senior Technician Mr. P.J. Thomas and Mr. Sunil Sharma. Also, we acknowledge Mr. Anil Kumar (Ph.D Student) for his assistance in making the graphical abstract.
Funding
This research was supported by a research fellowship provided to the student from Indian Council of Medical Research (ICMR), New Delhi, India. Indian Council of Medical Research
Author information
Authors and Affiliations
Contributions
Lekha Saha and Puja kumari : Protocol writing, Performing experiments, Data collections and analysis, Manuscript writing and final editing. Kajal Rawat, Vipasha Gautam, Neha Singh and Arushi Sandhu: Performing experiments, Manuscript writing and editing. Alka Bhatia, V R Sinha and Amitava Chakrabarti: Data Analysis,Manuscript writing and editing.
Corresponding author
Ethics declarations
Competing Interest
The researcher claims no conflicts of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saha, L., Kumari, P., Rawat, K. et al. Neuroprotective effect of Berberine Nanoparticles Against Seizures in Pentylenetetrazole Induced Kindling Model of Epileptogenesis: Role of Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Mechanisms. Neurochem Res 48, 3055–3072 (2023). https://doi.org/10.1007/s11064-023-03967-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-023-03967-z